Canada Pension Plan Investment Board boosted its stake in Illumina, Inc. (NASDAQ:ILMN) by 110.1% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 19,210 shares of the life sciences company’s stock after purchasing an additional 10,068 shares during the quarter. Canada Pension Plan Investment Board’s holdings in Illumina were worth $3,827,000 as of its most recent filing with the SEC.

Other institutional investors also recently added to or reduced their stakes in the company. First Citizens Bank & Trust Co. lifted its position in Illumina by 0.4% during the second quarter. First Citizens Bank & Trust Co. now owns 3,088 shares of the life sciences company’s stock valued at $536,000 after buying an additional 12 shares in the last quarter. Puzo Michael J lifted its position in Illumina by 0.4% during the second quarter. Puzo Michael J now owns 5,955 shares of the life sciences company’s stock valued at $1,032,000 after buying an additional 25 shares in the last quarter. Flagship Harbor Advisors LLC lifted its position in Illumina by 1.7% during the second quarter. Flagship Harbor Advisors LLC now owns 2,046 shares of the life sciences company’s stock valued at $345,000 after buying an additional 35 shares in the last quarter. Broderick Brian C lifted its position in Illumina by 0.3% during the second quarter. Broderick Brian C now owns 13,152 shares of the life sciences company’s stock valued at $2,282,000 after buying an additional 40 shares in the last quarter. Finally, Nordea Investment Management AB lifted its position in Illumina by 0.6% during the second quarter. Nordea Investment Management AB now owns 6,798 shares of the life sciences company’s stock valued at $1,180,000 after buying an additional 42 shares in the last quarter. Hedge funds and other institutional investors own 92.70% of the company’s stock.

In related news, SVP Oene Mark Van sold 9,729 shares of the company’s stock in a transaction on Tuesday, September 12th. The shares were sold at an average price of $211.33, for a total value of $2,056,029.57. Following the sale, the senior vice president now directly owns 24,908 shares of the company’s stock, valued at $5,263,807.64. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Jay T. Flatley sold 2,540 shares of the business’s stock in a transaction on Monday, August 28th. The shares were sold at an average price of $197.39, for a total transaction of $501,370.60. Following the sale, the director now owns 539,176 shares of the company’s stock, valued at approximately $106,427,950.64. The disclosure for this sale can be found here. Insiders sold 170,446 shares of company stock worth $35,075,154 over the last ninety days. 1.60% of the stock is currently owned by corporate insiders.

A number of brokerages have weighed in on ILMN. Barclays PLC reaffirmed an “equal weight” rating and set a $150.00 price target on shares of Illumina in a research report on Wednesday, August 9th. Vetr raised shares of Illumina from a “hold” rating to a “buy” rating and set a $209.78 price target on the stock in a research report on Wednesday, August 9th. BidaskClub raised shares of Illumina from a “sell” rating to a “hold” rating in a research report on Monday, August 7th. Cowen and Company reaffirmed an “outperform” rating and set a $200.00 price target on shares of Illumina in a research report on Wednesday, August 2nd. Finally, Goldman Sachs Group, Inc. (The) reaffirmed a “neutral” rating and set a $200.00 price target on shares of Illumina in a research report on Tuesday, September 26th. Two investment analysts have rated the stock with a sell rating, nine have issued a hold rating and thirteen have issued a buy rating to the company’s stock. Illumina presently has an average rating of “Hold” and an average target price of $200.88.

Shares of Illumina, Inc. (NASDAQ ILMN) opened at $205.42 on Thursday. The stock has a market cap of $30,083.30, a price-to-earnings ratio of 60.25, a P/E/G ratio of 3.40 and a beta of 0.74. The company has a quick ratio of 3.73, a current ratio of 4.22 and a debt-to-equity ratio of 0.41. Illumina, Inc. has a twelve month low of $119.37 and a twelve month high of $214.50.

Illumina (NASDAQ:ILMN) last posted its quarterly earnings results on Tuesday, October 24th. The life sciences company reported $1.11 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.99 by $0.12. The firm had revenue of $714.00 million for the quarter, compared to analysts’ expectations of $692.77 million. Illumina had a net margin of 30.34% and a return on equity of 19.42%. The firm’s quarterly revenue was up 17.6% on a year-over-year basis. During the same period in the prior year, the company posted $0.97 earnings per share. equities analysts predict that Illumina, Inc. will post 3.75 EPS for the current fiscal year.

ILLEGAL ACTIVITY WARNING: “Illumina, Inc. (ILMN) Position Raised by Canada Pension Plan Investment Board” was reported by Watch List News and is the property of of Watch List News. If you are reading this story on another website, it was illegally copied and reposted in violation of international trademark and copyright laws. The correct version of this story can be viewed at https://www.watchlistnews.com/illumina-inc-ilmn-position-raised-by-canada-pension-plan-investment-board/1706630.html.

Illumina Company Profile

Illumina, Inc (Illumina) is a provider of sequencing- and array-based solutions for genetic analysis. The Company operates through two segments: Core Illumina and the consolidated variable interest entities (VIEs), which include the activities of GRAIL, Inc (GRAIL) and Helix Holdings I, LLC (Helix). Core Illumina consists of its core operations.

Institutional Ownership by Quarter for Illumina (NASDAQ:ILMN)

Receive News & Ratings for Illumina Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Illumina Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.